MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,298 | -9.9% | 17,285 | -7.8% | 0.00% | – |
| Q2 2023 | $24,745 | -61.6% | 18,746 | -79.4% | 0.00% | – |
| Q1 2023 | $64,394 | -55.5% | 91,093 | -52.8% | 0.00% | – |
| Q4 2022 | $144,722 | -3.5% | 192,962 | +11.0% | 0.00% | – |
| Q3 2022 | $150,000 | +500.0% | 173,786 | +689.1% | 0.00% | – |
| Q2 2022 | $25,000 | -84.3% | 22,024 | -53.4% | 0.00% | – |
| Q1 2021 | $159,000 | +93.9% | 47,219 | +105.0% | 0.00% | – |
| Q4 2020 | $82,000 | – | 23,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |